| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/03/2007 | WO2007048186A1 Leukocyte-binding polypeptides and uses thereof |
| 05/03/2007 | WO2007030937A3 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| 05/03/2007 | WO2007028985A3 Adjuvanted vaccine |
| 05/03/2007 | WO2007028592B1 Influencing cardial fc-receptors for treating dilatative cardiomyopathy |
| 05/03/2007 | WO2007025781A3 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 05/03/2007 | WO2007022416A3 Single chain antibodies against beta-amyloid peptide |
| 05/03/2007 | WO2007015841A3 A method for treating preeclampsia |
| 05/03/2007 | WO2007011941A3 Human anti-b7rp1 neutralizing antibodies |
| 05/03/2007 | WO2007002571A3 Use of an anti c5 complement antibody to treat patients with sickle cell disease |
| 05/03/2007 | WO2006138670A3 Antibody complexes |
| 05/03/2007 | WO2006125012A3 Compositions, methods and kits for real-time nucleic acid analysis in live cells |
| 05/03/2007 | WO2006099875A8 Antibodies against cd38 for treatment of multiple myeloma |
| 05/03/2007 | WO2006081516A3 USE OF BAFF TO TREAT Th2-MEDIATED CONDITIONS |
| 05/03/2007 | WO2005037989A3 Binding domain-immunoglobulin fusion proteins |
| 05/03/2007 | WO2005026317A3 Polynucleotides encoding novel variants of the trp channel family member, ltrpc3 |
| 05/03/2007 | WO2004111198A3 Modified human acid sphingomyelinase having increased activity, and methods for making the same |
| 05/03/2007 | WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF |
| 05/03/2007 | US20070101451 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/03/2007 | US20070101450 DNA that encodes a protein having high-affinity choline transporter activity |
| 05/03/2007 | US20070101446 Antibodies against epitopes with homology to self antigens, methods of preparation |
| 05/03/2007 | US20070099271 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 05/03/2007 | US20070099253 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
| 05/03/2007 | US20070099252 Diagnostic application of mail |
| 05/03/2007 | US20070099247 Polypeptide Display Libraries and Methods of Making and Using Thereof |
| 05/03/2007 | US20070099246 Antibodies, assays and kits to quantitate cartilage destruction |
| 05/03/2007 | US20070099241 Method of detecting a subfraction of proBNP |
| 05/03/2007 | US20070099217 Method for stress evaluation |
| 05/03/2007 | US20070099214 Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer |
| 05/03/2007 | US20070099181 isolation and characterization of new porcine circovirus (PCV) isolates from pigs displaying postweaning multisystemic wasting syndrome (PMWS). |
| 05/03/2007 | US20070099176 Methods of expressing LIM mineralization protein |
| 05/03/2007 | US20070098741 Vectors derived from antibodies for transferring substances into cells |
| 05/03/2007 | US20070098737 Streptococcal streptolysin S vaccines |
| 05/03/2007 | US20070098731 Treatment of infection due to clostridium difficile |
| 05/03/2007 | US20070098730 using a glycoconjugate comprising a dendrimeric or linear poly-Lysine enabling multiple epitopes to be covalently attached thereto; anticancer or antitumor agents |
| 05/03/2007 | US20070098729 Involves STEAP (six transmembrane epithelial antigen of the prostate); exposing cell to paclitaxel, androgen blocker, or immunomodudulator conjugated to antibody or fragment; drug delivery; diagnosis and therapy of prostate cancer, colon cancer, bladder cancer, ovarian cancer and pancreatic cancer; |
| 05/03/2007 | US20070098726 Methods of making and using antibodies directed to parathyroid hormone |
| 05/03/2007 | US20070098725 Antibody against fragments of apo-lipoprotein B; ischemic cardiovascular diseases |
| 05/03/2007 | US20070098724 Methods of Treatment Using Vascular Occlusion in Combination with One or More Therapies |
| 05/03/2007 | US20070098723 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 05/03/2007 | US20070098722 Medicament comprising inhibitors of long pentraxin ptx3 |
| 05/03/2007 | US20070098721 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
| 05/03/2007 | US20070098720 Cd40-binding apc-activating molecules |
| 05/03/2007 | US20070098719 GITR binding molecules and uses therefor |
| 05/03/2007 | US20070098718 Methods of therapy for b cell-related cancers |
| 05/03/2007 | US20070098717 Methods of therapy for solid tumors expressing the cd40 cell-surface antigen |
| 05/03/2007 | US20070098716 immunomodulatory agents that potentiate the effect of TLR agonists; autoimmune disease |
| 05/03/2007 | US20070098715 Antibodies against the tenascin major antigens |
| 05/03/2007 | US20070098712 Method for making multispecific antibodies having heteromultimeric and common components |
| 05/03/2007 | US20070098711 produces anti-Staphylococcus antibodies; monoclonal antibody is produced by providing a population of B-lymphocytes from a donor, immortalizing the population, separating a plurality of cells from the population to yield a first oligoclonal cell culture, culturing the the cell culture; |
| 05/03/2007 | US20070098707 Methods and Compositions for Inhibiting C-MET Dimerization and Activation |
| 05/03/2007 | US20070098688 Polymer conjugates of interferon beta-1a and uses |
| 05/03/2007 | CA2627457A1 Botulinum neurotoxin a protein receptor and uses thereof |
| 05/03/2007 | CA2627309A1 Pseudomonas aeruginosa outer membrane protein pa5158 |
| 05/03/2007 | CA2626939A1 Agents that bind a target in pulmonary tissue for treating respiratory diseases |
| 05/03/2007 | CA2626214A1 Novel use of il-1beta compounds |
| 05/02/2007 | EP1780278A2 Mammalian calcium channels and related probes, cell lines and methods |
| 05/02/2007 | EP1780277A1 IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
| 05/02/2007 | EP1780275A1 Polypeptide having a delta 5 fatty acid unsaturating activity, polynucleotide coding for the polypeptide and use thereof |
| 05/02/2007 | EP1780273A1 Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 05/02/2007 | EP1780268A2 PSCA: Prostate stem cell antigen and uses thereof |
| 05/02/2007 | EP1780221A1 Anti-synoviolin antibody |
| 05/02/2007 | EP1780220A1 Use of CEACAM8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| 05/02/2007 | EP1780219A2 Protein S polypeptides and uses thereof |
| 05/02/2007 | EP1780217A1 Molecular structure of RHD negative locus |
| 05/02/2007 | EP1780216A1 Pantropic canine coronavirus |
| 05/02/2007 | EP1778879A2 Antibodies against west nile virus and therapeutic and prophylactic uses thereof |
| 05/02/2007 | EP1778875A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 05/02/2007 | EP1778728A2 Polypeptide variants with altered effector function |
| 05/02/2007 | EP1778727A1 Antibody specific for a chondroitin sulphate epitope |
| 05/02/2007 | EP1778726A2 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 05/02/2007 | EP1778721A1 Modified hiv-1 peptides and use thereof in the detection of anti-hiv antibodies |
| 05/02/2007 | EP1778284A1 Nucleic acids and corresponding proteins entitled 58p1d12 useful in treatment and detection of cancer |
| 05/02/2007 | EP1778282A1 Mutated hiv nef for modulating immunity |
| 05/02/2007 | EP1778270A2 Bispecific binding agents for modulating biological activity |
| 05/02/2007 | EP1365797B1 Antibodies modulating the upa/upar interaction and uses thereof |
| 05/02/2007 | EP1261372B1 Method of treating cancer with anti-neurotrophin agents |
| 05/02/2007 | EP1151013B1 Monoclonal antibody against protein c inhibitor |
| 05/02/2007 | EP1100921B1 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/02/2007 | EP1077721B1 Prevention and treatment of hypergastrinemia |
| 05/02/2007 | EP1077069B1 Preventives/remedies for hepatic cirrhosis |
| 05/02/2007 | EP1004313B1 Cachexia remedy |
| 05/02/2007 | EP0998305B1 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 05/02/2007 | EP0953047B1 Vaccine containing a peroxiredoxin |
| 05/02/2007 | EP0906426B1 Antibodies to the ed-b domain of fibronectin, their construction and uses |
| 05/02/2007 | CN1957256A Methods and compositions for the detection of cervical disease |
| 05/02/2007 | CN1956738A Antibodies to MAdCAM |
| 05/02/2007 | CN1956731A Anti-CD52 antibody treatment for diabetes |
| 05/02/2007 | CN1955737A Protein chip for screening precancerous lesion of cancer of esophagus |
| 05/02/2007 | CN1313603C Human ovary carcinoma resisting monoclonal antibody hybridoma cell line and its monoclonal antibody and application |
| 05/02/2007 | CN1313150C Therapeutic agent for treating autoimmune diseases |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/01/2007 | US7211645 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 05/01/2007 | US7211566 a nonapeptide analog; antiinflammatory, antidiabetic agents, analgesics, antiastmatic agents |
| 05/01/2007 | US7211424 Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity |
| 05/01/2007 | US7211408 Comprising at least two regions, each region preferably having human T cell stimulating activity and each region comprising at least one T cell epitope derived from a protein antigen |
| 05/01/2007 | US7211405 Polypeptide for use in the detection of pregnancy complications |
| 05/01/2007 | US7211400 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 05/01/2007 | US7211398 Human genes and gene expression products: II |
| 05/01/2007 | US7211397 Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection |
| 05/01/2007 | US7211396 Selecting antibodies against MBL with different binding characteristics, using them to measure MBL capable of binding to mannan ; useful in diagnosing risk of autoimmune diseases |